Yousif Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $454K | Buy |
14,380
+13
| +0.1% | +$411 | ﹤0.01% | 1501 |
|
2025
Q1 | $477K | Buy |
14,367
+42
| +0.3% | +$1.39K | 0.01% | 1449 |
|
2024
Q4 | $493K | Buy |
14,325
+2,622
| +22% | +$90.2K | 0.01% | 1483 |
|
2024
Q3 | $468K | Sell |
11,703
-1,209
| -9% | -$48.4K | 0.01% | 1524 |
|
2024
Q2 | $390K | Sell |
12,912
-2,041
| -14% | -$61.6K | ﹤0.01% | 1583 |
|
2024
Q1 | $502K | Sell |
14,953
-1,405
| -9% | -$47.2K | 0.01% | 1511 |
|
2023
Q4 | $528K | Sell |
16,358
-325
| -2% | -$10.5K | 0.01% | 1504 |
|
2023
Q3 | $547K | Buy |
16,683
+721
| +5% | +$23.6K | 0.01% | 1439 |
|
2023
Q2 | $562K | Sell |
15,962
-831
| -5% | -$29.2K | 0.01% | 1443 |
|
2023
Q1 | $548K | Sell |
16,793
-2,200
| -12% | -$71.8K | 0.01% | 1449 |
|
2022
Q4 | $1.05M | Sell |
18,993
-4,890
| -20% | -$269K | 0.01% | 1133 |
|
2022
Q3 | $1.06M | Buy |
23,883
+4,944
| +26% | +$219K | 0.02% | 1165 |
|
2022
Q2 | $924K | Sell |
18,939
-1,940
| -9% | -$94.6K | 0.01% | 1278 |
|
2022
Q1 | $1.02M | Buy |
20,879
+710
| +4% | +$34.6K | 0.01% | 1350 |
|
2021
Q4 | $860K | Buy |
+20,169
| New | +$860K | 0.01% | 1432 |
|